Cargando…
Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors
Variant liver oestrogen receptor transcripts in hepatocellular carcinoma are associated with aggressive clinical course and unresponsiveness to tamoxifen. To evaluate the impact on survival and on tumour growth of megestrol (progestin drug acting at post-receptorial level) we enrolled 45 patients wi...
Autores principales: | Villa, E, Ferretti, I, Grottola, A, Buttafoco, P, Buono, M Grazia Del, Giannini, F, Manno, M, Bertani, H, Dugani, A, Manenti, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363845/ https://www.ncbi.nlm.nih.gov/pubmed/11286465 http://dx.doi.org/10.1054/bjoc.2000.1534 |
Ejemplares similares
-
Megestrol treatment in patients with hepatocellular carcinoma
por: Farinati, F, et al.
Publicado: (2001) -
A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss
por: McMillan, D C, et al.
Publicado: (1999) -
Megestrol acetate in cachexia and anorexia
por: Yeh, Shing-shing, et al.
Publicado: (2006) -
Efficacy and safety of megestrol in the management of hepatocellular carcinoma: a systematic review of the literature
por: Rawla, Prashanth, et al.
Publicado: (2018) -
The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function
por: Miodini, P, et al.
Publicado: (1999)